1. Pink Sheet
  2. >>R&D
  3. >>Clinical Trials

Ketek's Political Fallout

 
• By Kate Rawson

The negative attention from Capitol Hill over the approval of the antibiotic Ketek is impacting much more than the commercial prospects of a single drug: it's making FDA reviewers think twice about other applications.

Die-hard optimists who think that the Food & Drug Administration’s drug review process isn’t influenced by Capitol Hill politics, think again.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D